Aimei Health Technology (AFJK) Liabilities and Shareholders Equity (2023 - 2025)

Aimei Health Technology (AFJK) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $45.5 million in Q3 2025.

• Liabilities and Shareholders Equity for Q3 2025 came in at $45.5 million, down 37.53% year-over-year; the trailing twelve-month figure through Sep 2025 was $207.4 million (down 27.58% YoY), and the FY2024 annual result was $73.8 million, up 4.75% from the prior year.
• Liabilities and Shareholders Equity improved to $45.5 million in Q3 2025 per AFJK's latest filing, from $44.6 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $73.8 million in Q4 2024 and troughed at $43.6 million in Q1 2025.
• A 3-year average of $61.7 million and a median of $70.9 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity climbed 4.75% in 2024, then plunged 38.83% in 2025.
• A 3-year view of Liabilities and Shareholders Equity shows it stood at $70.5 million in 2023, then rose by 4.75% to $73.8 million in 2024, then slumped by 38.4% to $45.5 million in 2025.
• Business Quant data shows AFJK's Liabilities and Shareholders Equity at $45.5 million in Q3 2025, $44.6 million in Q2 2025, and $43.6 million in Q1 2025.